发明名称 Balanced physiological monitoring and treatment system
摘要 A system and method for providing balanced, automated regulation of a patient's physiological condition by monitoring at least one physiological parameter and, optionally, monitoring and controlling additional physiological parameters, is disclosed. The system includes a physiological parameter monitor, an intelligent control device and a multi-channel delivery device for providing controlled intravenous delivery of at least two medications that affect the physiological condition being controlled. Control logic in the intelligent control device is derived by an algorithm based on model predictive control. The control logic includes mathematically modeled systems, empirical data systems or a combination thereof. The system of the present invention is optionally included in a networked system to provide centralized data storage and archival of system information as well as data export and query capabilities that can be used for patient file management, health care facility management and medical research.
申请公布号 US9421332(B2) 申请公布日期 2016.08.23
申请号 US201514596916 申请日期 2015.01.14
申请人 ADMETSYS CORPORATION 发明人 Valk Jeffrey W.;Valk Timothy W.
分类号 A61B5/00;A61M5/172;A61B5/021;A61B5/024;A61B5/026;A61B5/145;A61M5/168;A61B5/02;A61B5/029;G06F19/00 主分类号 A61B5/00
代理机构 Fox Rothschild LLP 代理人 Wrigley Barbara A.;Fox Rothschild LLP
主权项 1. A system for monitoring and controlling a physiological condition of a patient, comprising: at least one physiological parameter monitor adapted to monitor at least one physiological parameter of a patient; a control device operably connected to said at least one physiological parameter monitor, said control device having control logic for optimization of patient-specific sensitivity to dosage by monitoring, receiving and storing physiological parameter data generated from said physiological parameter monitor and translating said physiological parameter data into an output control signal containing information regarding administration of at least two counterbalancing medications based on said patient-specific sensitivity to dosage; and a multi-channeled delivery mechanism operably connected to said control device and capable of receiving said output control signal from said control device, said multi-channeled delivery mechanism being structured to infuse said at least two counterbalancing medications into the patient based on said patient-specific sensitivity to dosage information contained in said output control signal.
地址 Boston MA US